Average Co-Inventor Count = 11.34
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (16 from 1,970 patents)
16 patents:
1. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
2. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
3. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
4. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
5. 9296734 - Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
6. 9174992 - Heterobicyclic compounds
7. 9090593 - Bicyclic compounds as Pim inhibitors
8. 9085576 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
9. 8957073 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
10. 8759532 - Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
11. 8637500 - Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
12. 8329700 - Pyrazine compounds as phosphodiesterase 10 inhibitors
13. 8318718 - Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
14. 8247418 - Pyrazine compounds as phosphodiesterase 10 inhibitors
15. 7872128 - Benzisoxazole and isoxazolo-pyridine compounds and method of use